Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Study reveals how liver bile composition changes during enteric infections November 26, 2024 New method revolutionizes in vivo brain imaging in awake mice March 4, 2024 The cut-off for HbA1c-based diagnosis of diabetes may be too high in women October 4, 2023